Obstetrics and Gynecology

1046 questions

Question 421Question →

A 27-year-old woman, gravida 1, para 0, is admitted to the hospital at 39 weeks gestation in active labor. Her prenatal course was uncomplicated. Epidural analgesia is initiated for pain management when her cervical dilation is 5 cm. Fifteen minutes after the epidural placement, the patient complains of sudden dizziness and nausea. Her blood pressure drops to 88/55 mm Hg, and her pulse increases to 105/min. The external fetal monitor reveals a baseline fetal heart rate of 145/min with moderate variability. There are recurrent, symmetric, gradual decreases in the fetal heart rate that reach their nadir after the peak of each uterine contraction; the heart rate returns to baseline only after the contraction has ended. Which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Repositioning the patient to the left lateral decubitus position

Answer

Repositioning the patient to the left lateral decubitus position
The correct answer is repositioning the patient to the left lateral decubitus position. This patient is experiencing late decelerations caused by uteroplacental insufficiency secondary to maternal hypotension. Epidural anesthesia frequently causes a sympathetic blockade that leads to systemic vasodilation, venous pooling, and subsequent hypotension. This acute drop in maternal blood pressure directly decreases blood flow to the placenta, resulting in fetal hypoxia and late decelerations. The initial step in intrauterine resuscitation for this condition is maternal repositioning to the left lateral decubitus position. This simple maneuver physically displaces the heavy gravid uterus off the inferior vena cava, thereby increasing venous return, maternal cardiac output, and uteroplacental perfusion. This positional change is typically accompanied by an intravenous isotonic fluid bolus, and if refractory, a vasopressor like ephedrine or phenylephrine.

Step-by-Step Solution

1
Identify the cause of the maternal symptoms.
The patient developed sudden hypotension (88/55 mm Hg) shortly after epidural placement, which is a classic presentation of epidural-induced sympathetic blockade leading to vasodilation and decreased venous return.
Recognizing the etiology of hypotension dictates the intervention.
2
Interpret the fetal heart rate tracing.
The tracing shows symmetric decreases that nadir after the peak of the contraction, which defines late decelerations. Late decelerations are a sign of uteroplacental insufficiency.
Connecting maternal hypotension to decreased placental perfusion explains the fetal distress.
3
Determine the initial management step.
The first step in intrauterine resuscitation is to improve maternal cardiac output and placental perfusion. This is achieved by repositioning the patient to the left lateral decubitus position.
This position shifts the gravid uterus off the inferior vena cava, increasing venous return to the heart and subsequently improving blood flow to the placenta.

Key Concept

Epidural-induced maternal hypotension leading to late decelerations should be initially managed with intrauterine resuscitation, starting with maternal repositioning and intravenous fluid boluses.
Question 422Question →

A 29-year-old multiparous patient develops heavy vaginal bleeding shortly after an uncomplicated vaginal delivery of a macrosomic infant. Examination reveals a boggy uterus positioned above the umbilicus. Arrange the following management steps for this patient's condition in the correct escalating sequence, from first-line intervention to the definitive final treatment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing postpartum hemorrhage due to uterine atony begins with bimanual massage and oxytocin, followed by second-line uterotonics, intrauterine balloon tamponade, uterine compression sutures, and finally hysterectomy as a last resort.
The standard protocol for uterine atony follows a strict progression from least to most invasive. It starts with bimanual massage and oxytocin. If unsuccessful, other uterotonics (methylergonovine, carboprost) are administered. Continued bleeding warrants intrauterine balloon tamponade. If mechanical tamponade fails, laparotomy for uterine compression sutures (e.g., B-Lynch) is performed. Hysterectomy is the definitive, life-saving final step.

Step-by-Step Solution

1
Identify the underlying cause of the postpartum hemorrhage based on the clinical presentation.
The physical finding of a boggy, enlarged uterus confirms uterine atony as the primary etiology.
Uterine atony requires a specific algorithmic approach focusing on restoring uterine tone before considering surgical options.
2
Determine the initial, least invasive intervention.
Bimanual massage and intravenous oxytocin.
First-line therapy aims to mechanically and pharmacologically stimulate uterine contractions with the lowest risk of adverse effects.
3
Establish the escalating sequence for refractory bleeding.
Second-line uterotonics, followed by balloon tamponade, conservative surgery, and finally definitive surgery.
Management must systematically progress from medical to mechanical to surgical interventions, reserving hysterectomy only for life-threatening hemorrhage unresponsive to all other measures.

Key Concept

Algorithmic stepwise management of postpartum hemorrhage secondary to uterine atony
Question 423Question →

An otherwise healthy 23-year-old primigravida presents to the labor and delivery unit at 39 weeks gestation reporting regular, painful uterine contractions. Her prenatal course was unremarkable. On admission, her cervix is dilated to 6 cm and 90% effaced, with the fetal vertex at -1 station. Continuous electronic fetal monitoring is initiated. The fetal heart rate tracing demonstrates a baseline of 140/min with moderate variability. There are recurrent, gradual decreases in the fetal heart rate that begin simultaneously with the onset of each contraction. The decelerations reach their nadir exactly at the peak of the contraction, and the heart rate returns to baseline precisely as the contraction ends. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Proceed with expectant observation of labor

Answer

Proceed with expectant observation of labor
The patient's fetal heart rate tracing demonstrates early decelerations, which are defined as visually apparent, gradual decreases in the fetal heart rate with a return to baseline associated with a uterine contraction. Crucially, the onset, nadir, and recovery of the deceleration coincide exactly with the beginning, peak, and end of the contraction. This is a physiologic response caused by fetal head compression during a contraction, which leads to altered cerebral blood flow, reflex vagal stimulation, and a subsequent transient decrease in heart rate. Early decelerations are benign and do not indicate fetal hypoxia or acidemia. Therefore, the most appropriate next step in management is expectant observation.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) tracing characteristics.
The FHR shows a normal baseline (140/min), moderate variability, and gradual decelerations that perfectly mirror the uterine contractions (nadir of deceleration matches peak of contraction).
Accurate interpretation of the FHR tracing is essential to determine fetal well-being and the need for intervention.
2
Classify the type of deceleration based on its relationship to uterine contractions.
The pattern is identified as early decelerations.
Gradual decreases in FHR (onset to nadir ≥ 30 seconds) that occur simultaneously with contractions represent early decelerations.
3
Determine the underlying pathophysiology and appropriate management.
Early decelerations are caused by fetal head compression, which triggers a reflex vagal response. They are benign and require no intervention.
Recognizing benign physiologic responses prevents unnecessary and potentially harmful obstetric interventions.

Key Concept

Early fetal heart rate decelerations are a benign physiologic response to fetal head compression and require expectant management without intervention.
Estimated Time:1m 0s
Question 424Question →

A 24-year-old nulligravid woman presents to the emergency department with severe, progressively worsening bilateral lower abdominal pain and fever for 3 days. Her temperature is 39.1°C (102.4°F), blood pressure is 105/65 mmHg, and pulse is 112/min. Physical examination reveals exquisite bilateral lower quadrant tenderness with involuntary guarding. Pelvic examination demonstrates purulent cervical discharge, pronounced cervical motion tenderness, and a palpable, exquisitely tender, 7-cm fluctuant mass in the right adnexa. A urine pregnancy test is negative.

Assuming standard protocols and a lack of clinical improvement following initial medical interventions, arrange the following management steps in the correct chronological sequence, from initial emergency department evaluation to ultimate definitive intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first obtain an endocervical NAAT, then perform a transvaginal ultrasound, followed by admission for IV antibiotics, then percutaneous drainage if medical therapy fails, and finally surgical intervention if drainage fails.
The management of a tubo-ovarian abscess (TOA) follows a strict escalation protocol. Initial evaluation in the emergency department must include endocervical swabs for microbiologic diagnosis (NAAT) during the speculum exam, prior to antibiotic administration. Following the physical exam, a transvaginal ultrasound is the imaging modality of choice to confirm the presence, size, and location of the suspected TOA. Once diagnosed, standard first-line therapy for unruptured TOAs involves hospital admission for broad-spectrum intravenous antibiotics (e.g., cefoxitin and doxycycline). If the patient demonstrates a failure of medical therapy—indicated by persistent fever, worsening pain, or leukocytosis after 48-72 hours—minimally invasive image-guided percutaneous drainage is the next indicated step. Finally, if percutaneous drainage fails or if signs of rupture/peritonitis develop, definitive surgical intervention (laparoscopy or laparotomy) is required.

Step-by-Step Solution

1
Identify the clinical presentation and severity
The patient has severe pelvic inflammatory disease with a palpable adnexal mass, highly suspicious for a Tubo-Ovarian Abscess (TOA).
Recognizing the severity and the likely presence of a TOA guides the immediate diagnostic and management steps.
2
Determine initial diagnostic steps in the emergency department
Endocervical NAAT must be obtained during the initial pelvic exam, followed by a transvaginal ultrasound to confirm the TOA.
Microbiologic diagnosis should precede antibiotics, and imaging confirms the clinical suspicion before initiating inpatient treatment protocols.
3
Establish first-line medical treatment
Hospital admission and intravenous antibiotics (e.g., cefoxitin and doxycycline).
Unruptured TOAs require inpatient monitoring and broad-spectrum IV coverage as initial management.
4
Determine escalation steps for medical treatment failure
Image-guided drainage, followed by surgical intervention if drainage fails.
Patients who fail to improve after 48-72 hours of IV antibiotics require source control, starting with the least invasive method (drainage) before progressing to surgery.

Key Concept

Management Escalation of Tubo-Ovarian Abscess (TOA)
Estimated Time:1m 30s
Question 425Question →

Match each patient profile with the most appropriate contraceptive method based on medical eligibility criteria and patient preferences.

Click a left item, then click its matching right item

Items

A 35-year-old woman who smokes 25 cigarettes daily and requests a highly effective, hormone-free contraceptive method.
A 24-year-old nulliparous woman with severe dysmenorrhea and heavy menstrual bleeding who is seeking long-acting contraception.
A 20-year-old healthy woman with moderate facial acne and irregular menses who desires a method to regulate her cycles.
A 28-year-old woman who is 3 weeks postpartum, exclusively breastfeeding, and prefers to take a daily pill.

Matches

Show answer & explanation

Answer

Match the 35-year-old smoker with the Copper intrauterine device, the 24-year-old with heavy bleeding with the Levonorgestrel-releasing intrauterine device, the 20-year-old with acne with the Combined oral contraceptive pill, and the 28-year-old postpartum woman with the Progestin-only pill.
Each correct match safely aligns a specific clinical profile with the safest and most beneficial contraceptive mechanism, strictly adhering to the World Health Organization Medical Eligibility Criteria.

Step-by-Step Solution

1
Analyze the profile of the 35-year-old smoker.
Identify that estrogen is contraindicated and select the Copper intrauterine device.
Combined hormonal contraceptives are absolutely contraindicated in women age 35 and older who smoke due to a high risk of cardiovascular events; she also requested a hormone-free method.
2
Evaluate the 24-year-old with heavy menstrual bleeding and dysmenorrhea.
Select the Levonorgestrel-releasing intrauterine device.
This device releases local progestin, which atrophies the endometrium, significantly reducing menstrual blood loss and pain.
3
Assess the 20-year-old with acne and irregular cycles.
Choose the Combined oral contraceptive pill.
The estrogen and progestin combination provides predictable withdrawal bleeding and decreases hyperandrogenism, effectively treating her acne.
4
Consider the 28-year-old who is 3 weeks postpartum and breastfeeding.
Select the Progestin-only pill.
Estrogen is contraindicated within the first month postpartum due to the hypercoagulable state of pregnancy; a progestin-only method meets her preference for a daily pill safely.

Key Concept

Applying the WHO Medical Eligibility Criteria for contraceptive use based on patient comorbidities and reproductive goals.
Question 426Question →

Match each of the following gynecologic neoplasms with the serum tumor marker that is most characteristically elevated in affected patients.

Click a left item, then click its matching right item

Items

Endodermal sinus (yolk sac) tumor
Granulosa cell tumor
Dysgerminoma
Serous cystadenocarcinoma

Matches

Show answer & explanation

Answer

Endodermal sinus (yolk sac) tumor matches with Alpha-fetoprotein (AFP); Granulosa cell tumor matches with Inhibin; Dysgerminoma matches with Lactate dehydrogenase (LDH); Serous cystadenocarcinoma matches with Cancer antigen 125 (CA-125).
Each gynecologic neoplasm is associated with a specific, characteristic tumor marker used for diagnosis and monitoring of disease. Endodermal sinus tumors produce AFP, granulosa cell tumors produce inhibin, dysgerminomas frequently present with elevated LDH, and epithelial tumors such as serous cystadenocarcinoma are monitored with CA-125.

Step-by-Step Solution

1
Identify the tumor marker for endodermal sinus (yolk sac) tumor.
Alpha-fetoprotein (AFP)
Yolk sac tumors are malignant germ cell tumors that characteristically secrete high levels of AFP.
2
Identify the tumor marker for granulosa cell tumor.
Inhibin
Granulosa cell tumors are sex cord-stromal tumors that typically secrete estrogen and inhibin, making inhibin a useful marker for diagnosis and monitoring.
3
Identify the tumor marker for dysgerminoma.
Lactate dehydrogenase (LDH)
Dysgerminomas are the most common malignant ovarian germ cell tumors and are typically associated with elevated LDH levels.
4
Identify the tumor marker for serous cystadenocarcinoma.
Cancer antigen 125 (CA-125)
Serous cystadenocarcinoma is the most common malignant epithelial ovarian cancer, which is characteristically monitored using serum CA-125 levels.

Key Concept

Gynecologic neoplasms and their associated serum tumor markers
Question 427Question →

A 56-year-old woman comes to the clinic for a well-woman examination. She feels well and has no current complaints. She experienced menopause at age 51 and denies any hot flashes, vaginal dryness, or postmenopausal bleeding. She takes no medications and has no significant past medical history. Her body mass index is 26 kg/m². Pelvic examination reveals normal external genitalia, a well-estrogenized vagina, and a grossly normal cervix without any visible lesions. A routine cervical cytology test is performed. Three days later, the cytology report indicates that the sample is negative for intraepithelial lesion or malignancy, but it notes the incidental presence of "benign-appearing endometrial cells." Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy is the mandatory next step to evaluate the uterine lining for hyperplasia or malignancy.
The correct answer is endometrial biopsy. Finding endometrial cells on cervical cytology in any postmenopausal woman, even if they are described as 'benign' and the patient is completely asymptomatic, is an abnormal clinical finding. It carries a significant risk of underlying endometrial hyperplasia or adenocarcinoma. According to established clinical guidelines, the mandatory next step is direct tissue sampling of the endometrium via an office biopsy.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
The patient is a 56-year-old asymptomatic postmenopausal woman.
Menopausal status is the critical determining factor for the management of incidental findings on gynecologic screening tests.
2
Evaluate the results of the cervical cytology.
The test is negative for cervical malignancy but shows benign-appearing endometrial cells.
Identifying all components of the cytology report ensures no clinically significant incidental findings are overlooked.
3
Apply evidence-based diagnostic guidelines for incidental endometrial cells based on menopausal status.
In postmenopausal women, the finding of any endometrial cells on a screening test requires a mandatory endometrial biopsy.
Despite appearing morphologically benign, the mere presence of shed endometrial cells in a postmenopausal woman suggests active endometrial proliferation, which carries a significant risk of underlying hyperplasia or adenocarcinoma.

Key Concept

The incidental finding of normal or benign-appearing endometrial cells on cervical cytology in any postmenopausal woman requires immediate evaluation with an endometrial biopsy to rule out endometrial carcinoma.
Question 428Question →

A 24-year-old primigravida at 10 weeks gestation presents to the emergency department with heavy vaginal bleeding and severe vomiting. Her blood pressure is 150/90 mmHg. Pelvic examination reveals a uterus sized consistent with a 16-week gestation. Transvaginal ultrasonography demonstrates a heterogeneous, complex intrauterine mass with multiple cystic spaces and no fetal parts. Quantitative serum β\beta-hCG is 250,000 mIU/mL. Assuming this patient's clinical course subsequently progresses to non-metastatic gestational trophoblastic neoplasia, arrange the following management and surveillance steps in the optimal chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Suction dilation and curettage, followed by weekly β\beta-hCG monitoring, staging with chest radiography and pelvic ultrasonography, single-agent methotrexate therapy, and finally monthly β\beta-hCG monitoring for one year.
The correct clinical pathway for a complete hydatidiform mole begins with surgical evacuation via suction dilation and curettage. Because approximately 15% of complete moles progress to gestational trophoblastic neoplasia (GTN), weekly quantitative serum β\beta-hCG monitoring is mandatory following evacuation. If GTN develops (diagnosed by rising or plateauing β\beta-hCG levels), the patient must undergo staging (chest radiograph and pelvic ultrasound, plus or minus brain/abdominopelvic imaging if symptomatic) to calculate the WHO prognostic score. For non-metastatic, low-risk GTN, single-agent chemotherapy (such as methotrexate or dactinomycin) is the standard of care. Following successful treatment (defined by three normal weekly β\beta-hCG levels), the patient enters a surveillance period of monthly β\beta-hCG checks for 12 months, during which strict contraception is required.

Step-by-Step Solution

1
Identify the primary presentation and immediate management
Complete hydatidiform mole requiring immediate uterine evacuation via suction dilation and curettage.
To treat the primary molar pregnancy and prevent severe immediate maternal complications (preeclampsia, hemorrhage, thyroid storm).
2
Establish early post-evacuation surveillance
Initiation of weekly β\beta-hCG monitoring.
Approximately 15-20% of complete moles undergo malignant transformation; weekly trending is the standard of care to detect GTN early.
3
Respond to malignant transformation (GTN diagnosis)
Staging imaging (chest radiography, pelvic ultrasound).
To rule out distant metastasis (commonly to the lungs) and calculate the WHO prognostic score prior to initiating chemotherapy.
4
Initiate targeted therapy based on prognostic staging
Single-agent methotrexate therapy.
The patient has assumed non-metastatic (low-risk) GTN, which is highly curable with single-agent chemotherapy regimens.
5
Establish long-term post-treatment surveillance
Monthly β\beta-hCG monitoring for one year.
To confirm a durable remission and detect any early recurrences while the patient remains on strict contraception.

Key Concept

Management pathway for Gestational Trophoblastic Disease (GTD) and Neoplasia (GTN)
Question 429Question →

An obstetrics and gynecology consultation is requested for a 71-year-old female due to persistent perineal pruritus that has been refractory to medical management over the past 14 months. The patient reports intense, burning itchiness localized to the right labial region. She has independently applied various over-the-counter hydrocortisone and clotrimazole preparations without symptomatic relief. Her past medical history is significant for well-controlled type 2 diabetes mellitus and primary hypertension. She underwent a screening colonoscopy 11 years ago, which was normal, and her last mammogram was performed 4 years ago. Physical examination of the external genitalia reveals a 3.5-cm sharply demarcated, brightly erythematous plaque with a 'velvety' texture and scattered white, hyperkeratotic patches on the right labium majus. There are no palpable inguinal lymph nodes. A 4-mm punch biopsy of the affected area is obtained. Histopathologic analysis demonstrates large, round cells with abundant pale cytoplasm and prominent nucleoli situated within the epidermis. Immunohistochemical staining is positive for cytokeratin 7 (CK7) and periodic acid-Schiff (PAS), but negative for cytokeratin 20 (CK20) and S100. Based on these findings, what is the most appropriate next step in patient management?

Show answer & explanation

Answer: Perform breast imaging, colonoscopy, and cystoscopy

Answer

Perform breast imaging, colonoscopy, and cystoscopy
The clinical presentation of a pruritic, intensely erythematous, 'velvety' plaque with hyperkeratotic white islands is classic for extramammary Paget disease (EMPD) of the vulva. The diagnosis is confirmed by the biopsy demonstrating large, pale intraepidermal Paget cells. The immunohistochemical profile (CK7-positive, PAS-positive, S100-negative) definitively distinguishes EMPD from vulvar melanoma (which would be S100-positive) and squamous cell carcinoma. While EMPD can occur as a primary intraepithelial neoplasm arising from apocrine glands, approximately 20% to 30% of cases are associated with a synchronous underlying internal adenocarcinoma, most commonly originating in the gastrointestinal tract, genitourinary tract, or breast. Because the presence of an internal malignancy significantly alters the patient's prognosis and sequence of treatments, it is mandatory to perform a comprehensive, age-appropriate screening (including colonoscopy, mammography, and cystoscopy) prior to definitive surgical excision of the vulvar lesion. This patient is overdue for both her colonoscopy and mammogram, making this systemic evaluation the critical next step.

Step-by-Step Solution

1
Interpret the clinical presentation and biopsy results.
The erythematous plaque with CK7-positive, PAS-positive, and S100-negative intraepidermal cells indicates Extramammary Paget Disease (EMPD).
These specific immunohistochemical markers differentiate EMPD from vulvar melanoma (which is S100-positive) and squamous cell carcinoma in situ.
2
Identify known systemic associations with the diagnosed condition.
Vulvar EMPD has a 20% to 30% incidence of synchronous underlying internal adenocarcinomas.
EMPD cells often represent an intraepithelial extension of an underlying glandular malignancy, most commonly from the gastrointestinal tract, genitourinary tract, or breast.
3
Determine the necessary sequential management protocol.
Systemic screening for GI, GU, and breast cancers is required prior to local excision.
Identifying a concurrent internal malignancy fundamentally alters the patient's prognosis and surgical priority, superseding immediate local treatment of the vulvar lesion.

Key Concept

Evaluation of vulvar Extramammary Paget Disease requires mandatory screening for synchronous underlying adenocarcinomas (GI, GU, and breast) prior to definitive local excision.
Question 430Question →

A healthy 25-year-old female visits the gynecology clinic for a routine wellness check. She underwent insertion of a levonorgestrel-releasing intrauterine device (IUD) twelve months ago. She reports feeling well with no pelvic pain, and she has experienced expected light spotting. However, she notes that she cannot palpate the device's strings, which she previously checked monthly. The patient's vital signs are stable. During speculum examination, the threads are not visualized protruding from the cervical os. Arrange the following diagnostic and management steps in the correct chronological sequence to evaluate this finding.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order for evaluating missing intrauterine device (IUD) strings is to first exclude pregnancy with a urine beta-hCG test, then attempt to retrieve retracted strings with a cytobrush, followed by a transvaginal ultrasound if strings are still not found, and finally an abdominal X-ray if the uterus is completely empty.
The correct algorithm for missing IUD strings minimizes risk and invasive procedures by starting with a pregnancy test to ensure safety, followed by a simple clinic maneuver (cytobrush) to solve the most common etiology. Imaging escalates from the safest modality (ultrasound) to radiographic evaluation only if the uterus is proven empty.

Step-by-Step Solution

1
Rule out pregnancy with a urine beta-hCG test.
Confirms whether the missing strings are due to an expelled IUD resulting in an unintended pregnancy.
Establishing pregnancy status is critical to ensure the safety of further instrumentation and guides subsequent patient counseling.
2
Sweep the endocervix gently with a cytobrush.
Often retrieves strings that have simply retracted into the cervical canal.
Retraction into the endocervix is the most common cause of missing strings; a quick in-office sweep can resolve the issue and avoid unnecessary, expensive imaging.
3
Perform a transvaginal ultrasound.
Identifies if the IUD is present and properly positioned within the uterine cavity.
When strings are completely absent from the cervix, imaging is required to confirm the device has not been unknowingly expelled or perforated through the myometrium.
4
Obtain an abdominal radiograph.
Locates the IUD within the abdominal cavity or confirms expulsion if absent from the image.
This differentiates between silent expulsion (no IUD seen) and uterine perforation (IUD seen in the abdomen), dictating whether laparoscopic retrieval is necessary.

Key Concept

Algorithmic evaluation of missing intrauterine device (IUD) strings
Question 431Question →

During the active phase of labor at 3939 weeks of gestation, a primigravid patient requests pain relief. An epidural catheter is placed and a standard dose of local anesthetic is administered. Ten minutes later, the patient reports feeling lightheaded and nauseated. Her blood pressure has decreased from a baseline of 120/75 mmHg120/75\text{ mmHg} to 85/50 mmHg85/50\text{ mmHg}, and her heart rate is 112/min112/\text{min}. Continuous electronic fetal monitoring, which previously demonstrated a baseline of 140/min140/\text{min} with moderate variability and no decelerations, now reveals a sudden decrease in the fetal heart rate to 85/min85/\text{min} that has persisted for 33 minutes. Uterine contractions are occurring every 44 minutes and are of normal intensity. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous administration of ephedrine

Answer

The correct intervention is the intravenous administration of a vasopressor such as ephedrine or phenylephrine to correct the maternal hypotension.
The correct response addresses the root cause of the fetal distress. Epidural anesthesia causes a sympathetic blockade that can result in profound peripheral vasodilation and maternal hypotension. This acute drop in maternal blood pressure reduces blood flow to the intervillous space, leading to decreased fetal oxygenation and a prolonged deceleration on the fetal monitor. The most direct and appropriate management is to restore maternal blood pressure using an intravenous vasopressor such as ephedrine or phenylephrine, typically accompanied by an IV fluid bolus and displacing the uterus off the major vessels by placing the patient in a left lateral decubitus position.

Step-by-Step Solution

1
Identify the primary complication occurring after the epidural placement.
The patient has developed symptomatic maternal hypotension (85/50 mmHg85/50\text{ mmHg}), a common side effect of neuraxial anesthesia due to sympathetic blockade and vasodilation.
Recognizing the iatrogenic cause of the vital sign changes is necessary to guide specific therapy.
2
Evaluate the fetal heart rate tracing in the context of the maternal status.
The fetal monitor shows a prolonged deceleration (a decrease of ≥15 bpm\geq 15\text{ bpm} lasting ≥2\geq 2 minutes but <10< 10 minutes).
Maternal hypotension leads to decreased uteroplacental blood flow, resulting in acute fetal hypoxia and a reflex bradycardia/deceleration.
3
Select the most appropriate intervention to address both the maternal and fetal status.
Administration of intravenous ephedrine (or phenylephrine) along with a fluid bolus and left lateral positioning.
Vasopressors directly counteract the sympathectomy-induced vasodilation, restoring maternal blood pressure, placental perfusion, and resolving the fetal deceleration.

Key Concept

Epidural anesthesia can cause sympathetic blockade leading to maternal hypotension, which decreases placental perfusion and manifests as a prolonged fetal heart rate deceleration. The initial management includes maternal repositioning, IV fluids, and vasopressors (e.g., ephedrine).
Question 432Question →

A 59-year-old female is evaluated in the primary care clinic for new-onset vaginal spotting that has occurred intermittently for the past three weeks. Her last menstrual period was 8 years ago. She has no significant past medical history except for well-controlled hypertension. Her body mass index is 33 kg/m2. Physical examination shows a normal appearing cervix and vaginal mucosa. Which of the following is the most appropriate next step in evaluating this patient's symptoms?

Show answer & explanation

Answer: Tissue sampling of the endometrium

Answer

Tissue sampling of the endometrium
Any episode of bleeding in a postmenopausal woman is abnormal and must be investigated promptly to rule out endometrial hyperplasia and cancer. The patient's obesity is an additional risk factor, as peripheral conversion of androgens to estrogens in adipose tissue leads to unopposed estrogen exposure. The standard of care for initial evaluation is either tissue sampling of the endometrium or a transvaginal ultrasound (to measure endometrial stripe thickness). Since ultrasound is not an option here, tissue sampling is the unequivocally correct next step.

Step-by-Step Solution

1
Identify the primary clinical problem from the vignette.
The patient is a 59-year-old postmenopausal woman with new-onset vaginal bleeding and risk factors for endometrial cancer, such as obesity.
Postmenopausal bleeding is the classic presentation for endometrial carcinoma and requires immediate evaluation.
2
Determine the standard diagnostic pathway for postmenopausal bleeding.
The initial evaluation for postmenopausal bleeding involves either tissue sampling to obtain a histologic diagnosis or transvaginal ultrasound to measure endometrial thickness.
Malignancy must be definitively ruled out before any other diagnosis is considered.
3
Select the most appropriate choice from the given options.
Tissue sampling of the endometrium is the only correct diagnostic modality listed.
Other options involve inappropriate observation, unnecessary laboratory testing, or contraindicated hormone therapies.

Key Concept

Postmenopausal bleeding requires immediate evaluation with endometrial tissue sampling or transvaginal ultrasound to rule out endometrial cancer.
Estimated Time:1m 0s
Question 433Question →

A 19-year-old woman visits the student health clinic reporting four days of dull, aching pain in her lower abdomen accompanied by new-onset spotting between her menstrual periods. She reports having a new sexual partner over the last month and admits to inconsistent use of barrier contraception. Her vital signs are within normal limits, including a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}). She is able to eat and drink without difficulty and does not appear acutely ill. On speculum examination, there is yellow, mucopurulent discharge visible at the cervical os. Bimanual examination demonstrates significant tenderness upon manipulation of the cervix, as well as bilateral adnexal tenderness. Urine pregnancy testing is negative. Which of the following represents the most appropriate initial treatment regimen for this patient?

Show answer & explanation

Answer: Intramuscular ceftriaxone, oral doxycycline, and oral metronidazole

Answer

The correct answer is the combination of intramuscular ceftriaxone, oral doxycycline, and oral metronidazole.
The patient's presentation of lower abdominal pain accompanied by cervical motion tenderness and adnexal tenderness is classic for pelvic inflammatory disease (PID). Because she is not pregnant, is tolerating oral intake without nausea or vomiting, and does not have signs of severe systemic illness or a tubo-ovarian abscess, she meets the criteria for outpatient management. The most appropriate initial treatment is a single dose of intramuscular ceftriaxone (to cover Neisseria gonorrhoeae) combined with a 14-day course of oral doxycycline (to cover Chlamydia trachomatis) and oral metronidazole (to cover anaerobic organisms).

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has lower abdominal pain, cervical motion tenderness, and adnexal tenderness, meeting the clinical criteria for pelvic inflammatory disease (PID).
Identifying the disease process is the first step in determining management.
2
Determine the appropriate level of care (inpatient vs. outpatient).
The patient is afebrile, non-toxic appearing, not pregnant, and tolerating oral intake.
Absence of severe features or indications for hospitalization means outpatient management is appropriate.
3
Select the guideline-concordant outpatient pharmacotherapy.
The standard CDC outpatient regimen consists of intramuscular ceftriaxone, oral doxycycline, and oral metronidazole.
This specific combination provides necessary coverage for Neisseria gonorrhoeae, Chlamydia trachomatis, and anaerobic vaginal flora.

Key Concept

Outpatient management of uncomplicated Pelvic Inflammatory Disease (PID) requires coverage for N. gonorrhoeae, C. trachomatis, and anaerobes using Ceftriaxone (IM), Doxycycline (PO), and Metronidazole (PO).
Estimated Time:1m 0s
Question 434Question →

A 27-year-old woman presents to her primary care physician because she has not menstruated for the past 66 months. She achieved menarche at age 14, and her menses have historically been regular, with bleeding lasting 4 days every 29 days. She works as a software engineer and exercises moderately twice a week. She recently started a new relationship and uses condoms for birth control. She has not noticed any breast discharge, changes in voice, or abnormal hair growth. Her body mass index is 24 kg/m224 \text{ kg/m}^2. Her vital signs are normal. Physical examination shows normal thyroid size and no skin findings suggestive of hyperandrogenism. A urine pregnancy test performed at the clinic is negative. Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Measurement of serum prolactin, thyroid-stimulating hormone, and follicle-stimulating hormone levels

Answer

The most appropriate next step is the measurement of serum prolactin, thyroid-stimulating hormone (TSH), and follicle-stimulating hormone (FSH) levels.
This patient presents with secondary amenorrhea (the cessation of regular menses for at least 3 months). After confirming that the patient is not pregnant—which is the single most common cause and the required first step in evaluation—the next most appropriate step is to evaluate the hypothalamic-pituitary-ovarian axis. Measuring serum prolactin, thyroid-stimulating hormone (TSH), and follicle-stimulating hormone (FSH) levels is the standard initial approach. This identifies the most frequent non-physiologic etiologies: hyperprolactinemia, thyroid dysfunction, and primary ovarian insufficiency.

Step-by-Step Solution

1
Identify the patient's primary presenting condition.
The patient has secondary amenorrhea, defined as the absence of menses for 3 or more months in a woman with previously regular cycles.
Establishing the correct definition directs the clinician to the appropriate diagnostic algorithm.
2
Review the initial test results provided in the vignette.
The point-of-care urine pregnancy test is negative.
Pregnancy is the most common cause of secondary amenorrhea and must always be ruled out as the first mandatory step.
3
Determine the next line of diagnostic testing based on standard medical guidelines.
Order serum prolactin, thyroid-stimulating hormone, and follicle-stimulating hormone levels.
These tests screen for the most frequent non-physiologic causes of secondary amenorrhea: hyperprolactinemia, thyroid disorders, and primary ovarian insufficiency.

Key Concept

After ruling out pregnancy, the initial biochemical evaluation of secondary amenorrhea involves measuring serum prolactin, thyroid-stimulating hormone (TSH), and follicle-stimulating hormone (FSH) levels.
Estimated Time:1m 0s
Question 435Question →

Match each common gynecologic infection with its characteristic clinical presentation and microscopic findings.

Click a left item, then click its matching right item

Items

Bacterial vaginosis
Trichomoniasis
Vulvovaginal candidiasis
Gonococcal cervicitis

Matches

Show answer & explanation

Answer

Bacterial vaginosis pairs with thin grayish discharge and clue cells. Trichomoniasis pairs with frothy yellow-green discharge and motile organisms. Vulvovaginal candidiasis pairs with thick white discharge and pseudohyphae. Gonococcal cervicitis pairs with mucopurulent exudate and gram-negative diplococci.
Each gynecologic infection has distinct hallmark findings. Bacterial vaginosis is identified by clue cells and a thin, homogeneous discharge. Trichomoniasis features motile, flagellated organisms in a frothy discharge, sometimes accompanied by a 'strawberry cervix' (punctate hemorrhages). Vulvovaginal candidiasis is distinguished by pseudohyphae on KOH prep, normal vaginal pH, and thick, cottage cheese-like discharge. Finally, gonococcal cervicitis is a classic cause of mucopurulent discharge showing gram-negative intracellular diplococci.

Step-by-Step Solution

1
Analyze the discharge characteristics and microscopy findings in the provided descriptions.
Identified key diagnostic phrases: clue cells, motile flagellated organisms, pseudohyphae, and intracellular diplococci.
These microscopic findings are pathognomonic for specific lower reproductive tract infections.
2
Correlate each pathognomonic finding with the correct causative organism.
Matched the specific descriptions to Bacterial vaginosis, Trichomoniasis, Vulvovaginal candidiasis, and Gonococcal cervicitis, respectively.
Correct identification of the pathogen determines the appropriate antimicrobial therapy.

Key Concept

Accurate diagnosis of common vaginitis and cervicitis requires correlating clinical discharge appearance with specific point-of-care testing such as vaginal pH, wet mount, and KOH preparation.
Question 436Question →

A 3535-year-old woman, gravida 22, para 11, at 4141 weeks gestation is admitted to the labor and delivery unit for induction of labor due to a post-term pregnancy. An intravenous oxytocin infusion is started. Six hours later, her cervix is 5 cm5\text{ cm} dilated and 90%90\% effaced, with the fetal vertex at −1-1 station. Uterine contractions are occurring every 4 minutes4\text{ minutes} and are of moderate intensity. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 120/75 mmHg120/75\text{ mmHg}, and pulse is 88/min88\text{/min}. Laboratory studies from admission show a hemoglobin of 10.6 g/dL10.6\text{ g/dL} and a platelet count of 210,000/mm3210,000\text{/mm}^3. The fetal heart rate monitoring demonstrates a baseline of 135/min135\text{/min} with minimal variability. Over the past 20 minutes20\text{ minutes}, the tracing reveals recurrent, gradual decreases in the fetal heart rate that begin after the peak of each contraction and take approximately 40 seconds40\text{ seconds} to reach their nadir. The fetal heart rate returns to baseline only after the contraction has fully ended. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue oxytocin infusion and reposition the patient laterally

Answer

Discontinue oxytocin infusion and reposition the patient laterally.
The patient's fetal heart rate tracing demonstrates late decelerations (a gradual decrease in heart rate beginning after the contraction peak), which are a hallmark sign of uteroplacental insufficiency. The first-line management for this Category II tracing is intrauterine resuscitation. This involves discontinuing uterotonic agents (such as oxytocin) to reduce uterine activity and maternal repositioning (typically to the left lateral decubitus position) to relieve aortocaval compression and maximize uterine blood flow. Additional resuscitative measures can include an intravenous fluid bolus and the administration of supplemental oxygen.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) tracing described in the stem.
The tracing shows recurrent decelerations with a gradual onset that begin after the peak of the contraction and return to baseline after the contraction ends.
Identifying the specific type of FHR deceleration is required to determine the underlying etiology and guide management.
2
Correlate the FHR pattern with its pathophysiology.
The pattern describes late decelerations, which are indicative of uteroplacental insufficiency.
Late decelerations reflect transient fetal hypoxemia during uterine contractions due to compromised placental perfusion, which is commonly seen in post-term pregnancies.
3
Determine the initial management for late decelerations in a patient receiving oxytocin.
The most appropriate next step is intrauterine resuscitation, starting with discontinuing the oxytocin infusion and repositioning the patient laterally.
Discontinuing oxytocin reduces uterine activity, thereby improving placental blood flow. Lateral maternal repositioning relieves aortocaval compression, further optimizing cardiac output and uterine perfusion.

Key Concept

Recurrent late decelerations indicate uteroplacental insufficiency and should initially be managed with intrauterine resuscitation, which includes discontinuing uterotonics (like oxytocin), lateral maternal repositioning, an intravenous fluid bolus, and supplemental oxygen.
Question 437Question →

A family planning clinic is evaluating multiple patients who are seeking reliable, reversible contraception. Each patient has distinct medical comorbidities that impact the safety of various contraceptive methods according to the World Health Organization Medical Eligibility Criteria (WHO MEC). Match each patient's clinical presentation with the single most appropriate contraceptive method.

Click a left item, then click its matching right item

Items

A 34-year-old woman with poorly controlled hypertension (162/104 mmHg) and severe dysmenorrhea.
A 28-year-old woman with systemic lupus erythematosus and positive antiphospholipid antibodies.
A 22-year-old woman with active Chlamydia trachomatis cervicitis who requests a long-acting contraceptive today.
A 38-year-old woman who smokes a pack of cigarettes daily and specifically requests a daily, orally administered contraceptive.

Matches

Show answer & explanation

Answer

The hypertensive patient with dysmenorrhea should receive the Levonorgestrel-releasing intrauterine device. The patient with SLE and antiphospholipid antibodies should receive the Copper intrauterine device. The patient with active cervicitis should receive the Subdermal etonogestrel implant. The 38-year-old smoker desiring an oral method should receive the Progestin-only pill.
Each patient presentation highlights a specific WHO MEC Category 4 (absolute) or Category 3 (relative) contraindication. Estrogen is contraindicated in severe hypertension and in smokers over age 35. All hormones are contraindicated in patients with positive antiphospholipid antibodies. IUD placement is contraindicated during active cervical infections.

Step-by-Step Solution

1
Evaluate the patient with severe hypertension and dysmenorrhea.
Exclude estrogen-containing methods; select a method that treats dysmenorrhea.
Estrogen exacerbates cardiovascular risk in severe hypertension. The levonorgestrel IUD provides excellent contraception while treating heavy or painful menses.
2
Evaluate the patient with SLE and positive antiphospholipid antibodies.
Exclude all hormonal (estrogen and progestin) methods.
Positive antiphospholipid antibodies confer an unacceptably high risk of thrombosis with hormonal methods. The copper IUD is the safest highly effective, hormone-free alternative.
3
Evaluate the patient with active cervicitis seeking a long-acting method.
Exclude all intrauterine devices; select the subdermal implant.
Inserting an IUD through an infected cervix can seed bacteria into the upper genital tract, causing pelvic inflammatory disease. The implant provides immediate, long-acting protection without this risk.
4
Evaluate the 38-year-old smoker requesting a daily pill.
Exclude combined oral contraceptives; select the progestin-only pill.
Age 35 or older combined with heavy smoking creates an unacceptable risk for myocardial infarction and stroke if given estrogen. The progestin-only pill meets her preference for a daily oral formulation safely.

Key Concept

World Health Organization Medical Eligibility Criteria (WHO MEC) for Contraceptive Use
Question 438Question →

Match each gynecologic malignancy with its most characteristic risk factor or pathogenetic association.

Click a left item, then click its matching right item

Items

Type I Endometrial Adenocarcinoma
Type II Endometrial (Serous) Carcinoma
Cervical Squamous Cell Carcinoma
Ovarian Clear Cell Carcinoma
Vaginal Clear Cell Adenocarcinoma

Matches

Show answer & explanation

Answer

Type I Endometrial Adenocarcinoma matches with chronic unopposed estrogen; Type II Endometrial Carcinoma matches with p53 mutations; Cervical Squamous Cell Carcinoma matches with high-risk HPV and tobacco use; Ovarian Clear Cell Carcinoma matches with endometriosis; Vaginal Clear Cell Adenocarcinoma matches with in utero DES exposure.
Each gynecologic malignancy arises from a specific pathophysiologic mechanism. Type I endometrial cancer depends on estrogen stimulation, while Type II is associated with p53 mutations and atrophy. Cervical cancer requires persistent HPV infection, exacerbated by smoking. Ovarian clear cell cancer is linked to the chronic inflammation of endometriosis, and vaginal clear cell adenocarcinoma is a historical consequence of in utero DES exposure.

Step-by-Step Solution

1
Analyze the pathogenesis of Type I versus Type II endometrial carcinoma.
Type I is driven by unopposed estrogen, whereas Type II occurs in atrophic endometrium and is associated with p53 mutations.
Distinguishing the two main types of endometrial cancer is essential for accurate risk factor matching.
2
Identify the primary risk factors for cervical and vaginal carcinomas.
Cervical cancer is strongly linked to high-risk HPV and smoking. Vaginal clear cell adenocarcinoma is uniquely associated with in utero DES exposure.
These are classic epidemiological associations in gynecologic oncology that are frequently tested.
3
Determine the association between endometriosis and specific ovarian cancers.
Endometriosis is a known precursor lesion specifically for clear cell and endometrioid carcinomas of the ovary.
Understanding the malignant transformation risk of benign gynecologic conditions guides diagnosis and surveillance.

Key Concept

Gynecologic malignancies have distinct risk factors and pathogenetic pathways that guide screening, prevention, and diagnosis.
Question 439Question →

A 23-year-old nulligravid woman presents to the emergency department with severe, worsening right-sided pelvic pain. Three days ago, she was diagnosed with pelvic inflammatory disease (PID) at an urgent care clinic, where she received a single dose of intramuscular ceftriaxone and was prescribed oral doxycycline and metronidazole. She reports worsening pain, subjective fevers, and an inability to tolerate the oral medications due to severe nausea. Her temperature is 39.0°C (102.2°F). Pelvic examination reveals exquisite cervical motion tenderness and a palpable, tender 5-cm mass in the right adnexa. A point-of-care urine pregnancy test is negative. Arrange the following steps in the most appropriate, evidence-based sequence for the ongoing management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: transvaginal ultrasonography, hospital admission, initiation of intravenous antibiotics, observation for 48-72 hours, and finally, evaluation for percutaneous drainage if medical therapy fails.
The correct sequence reflects the standard of care for a patient presenting with complicated pelvic inflammatory disease (PID) who has failed outpatient therapy. The presence of a new palpable adnexal mass and persistent fever despite initial antibiotic therapy raises high suspicion for a tubo-ovarian abscess (TOA). Because a pregnancy test was negative, the immediate next step is transvaginal ultrasonography to definitively diagnose and characterize the mass. Once a TOA is suspected or confirmed, the patient must be admitted to the hospital due to the severity of the condition and her inability to tolerate oral medications. The cornerstone of initial TOA management is the prompt administration of intravenous broad-spectrum antibiotics. Although a TOA is an abscess, first-line management for unruptured TOAs is medical, not surgical. The patient should be monitored closely; image-guided percutaneous drainage or surgical intervention is reserved for patients who fail to demonstrate clinical improvement (e.g., persistent fever, worsening pain) after a 48- to 72-hour trial of intravenous antibiotics, or for those presenting with signs of rupture.

Step-by-Step Solution

1
Identify the likely complication based on the physical exam and clinical history.
Suspected tubo-ovarian abscess (TOA)
The presence of a new palpable adnexal mass and failure of outpatient PID therapy strongly indicate a TOA.
2
Confirm the diagnosis.
Transvaginal ultrasound
Imaging is required to definitively diagnose and characterize the adnexal mass in the setting of acute pelvic pain.
3
Determine the appropriate clinical setting for treatment.
Hospital admission
A suspected TOA and the inability to tolerate oral medications are absolute indications for inpatient management.
4
Select the initial therapeutic intervention.
Intravenous antibiotics
First-line therapy for an unruptured TOA is medical, utilizing intravenous broad-spectrum antibiotics.
5
Establish criteria for procedural intervention.
Monitor for 48-72 hours before considering drainage
Drainage is reserved for cases refractory to initial medical management or in the event of suspected rupture.

Key Concept

The management of complicated pelvic inflammatory disease involving a tubo-ovarian abscess requires definitive imaging, hospital admission for intravenous antibiotics, and a 48- to 72-hour trial of medical therapy prior to considering invasive drainage.
Estimated Time:1m 0s
Question 440Question →

A 25-year-old nulliparous woman at 40 weeks gestation presents in spontaneous labor. Following an uncomplicated first stage, she is fully dilated, effaced, and at +1 station. The patient begins active maternal expulsive efforts. During this phase, the fetus must perform specific biomechanical adaptations to successfully navigate the maternal pelvis. Arrange the following cardinal movements of labor in the correct chronological sequence for a fetus in a standard vertex presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Engagement, Flexion, Internal rotation, Extension, External rotation (Restitution).
The cardinal movements of labor describe the physiological adaptations of the fetus during a vaginal delivery. For a cephalic presentation, the established chronological sequence is: (1) Engagement, where the fetal head enters the pelvic inlet; (2) Descent (which is continuous throughout); (3) Flexion, triggered by pelvic floor resistance, which presents the smallest head diameter; (4) Internal rotation, aligning the head anteroposteriorly; (5) Extension, where the head is delivered beneath the pubic symphysis; and (6) External rotation (restitution), where the newly delivered head realigns with the shoulders.

Step-by-Step Solution

1
Identify the initial entry into the pelvis.
Engagement.
The sequence begins when the fetal head enters the pelvic inlet.
2
Determine the response to pelvic resistance.
Flexion.
As descent continues, resistance from maternal tissues causes the fetal neck to flex, presenting the most optimal diameter for transit.
3
Identify the rotation within the birth canal.
Internal rotation.
The fetus must rotate its head to align the sagittal suture with the anteroposterior diameter of the midpelvis.
4
Determine how the head navigates the pelvic outlet.
Extension.
The pelvic curve directs the head upward, allowing it to emerge from the vaginal introitus by hinging under the pubic symphysis.
5
Identify the final adaptation before shoulder delivery.
External rotation (Restitution).
The delivered head unwinds to restore its anatomical alignment with the shoulders, which are simultaneously rotating internally.

Key Concept

The cardinal movements of labor are the sequential biomechanical and positional changes the fetus undergoes to adapt to the maternal pelvis during vaginal delivery.
PreviousPage 22 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 22 | Examkin